Short answer
Guardian Pharmacy Services, Inc. (GRDN) filed its Q3 2025 10-Q quarterly report on Nov 10, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $377M (down 57.6% year over year) with net income of $10M.
Q3 2025 key financials · XBRL
- Revenue
- $377M
- −57.6% YoY · +9.6% QoQ
- Net income
- $10M
- +108.0% YoY · +8.7% QoQ
- Operating margin
- 4.3%
- Gross margin
- 19.8%
Source: XBRL data from the Guardian Pharmacy Services, Inc. (GRDN) Q3 2025 10-Q on SEC EDGAR. USD.
Guardian Pharmacy Services, Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 revenue $377.4M, up 20.0% YoY from $314.4M
- Gross margin 19.8% vs 19.4% YoY
- Organic growth $43.0M; acquisitions contributed $20.0M
- Adjusted EBITDA $27.3M vs $23.0M YoY
- Interest expense $0.2M vs $1.0M, with no Credit Facility balance outstanding
Risk Factors
- No material changes to risk factors described in the December 31, 2024 Form 10-K
- No newly added risk factor or quarter-specific trigger disclosed
- No updated regulatory, legal, or compliance risk identified
- No changed operational, competitive, market, liquidity, debt, currency, or concentration risk identified
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Guardian Pharmacy Services, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.